This document contains 20 multiple choice questions about bladder cancer. It covers risk factors, presentation, diagnosis, staging, types of bladder cancer, treatment options including transurethral resection, intravesical BCG, chemotherapy, and cystectomy. The questions address topics such as the peak age of occurrence, male to female ratio, diagnostic imaging tools, proportion of cases that are non-muscle invasive, progression rates, TNM staging, treatment of carcinoma in situ, and standards for treating localized versus metastatic disease.

1. Bladder cancer, MCQ
Ahmad ElAbbady,MD
Professor, Urology Department
University of Alexandria

2. Bladder cancer, MCQ
Q1- Risk factors for development of Bladder Ca
include all the following except:
A-Tobacco smooking
B- Industrial carcinogens: e.g. aniline dyes.
C-Chronic irritation e.g. infection, stones
D- Excessive fat consumption
E-Pelvic irradiation

4. Bladder cancer, MCQ
Q2-Bladder extrophy predispose, specially with
delayed closure, to:
A- Adenocarcinoma
B- Transitional CC
C- Squamous CC
D- Undifferentiated Carcinoma

5. Bladder cancer, MCQ
Q3- Although bladder cancer occurs in different
age groups, the peak age is:
A- 3rd-4th decades.
B- 4th-5th decades.
C- 5th-6th decades.
D- 6th-8th decades.

6. Bladder cancer, MCQ
Q4- As regards incidence of bladder cancer male
to female ratio is
A- 3:1.
B- 2:1.
C- 1:1.
D- 4:1

7. Bladder cancer, MCQ
Q5- The most common early presentation of
bladder cancer is:
A- Irritative LUTS
B- Hematuria
C-S.P. pain
D- Accidental diagnosis

8. Bladder cancer, MCQ
Q6- All the following radiological tools could be
used for diagnosis of bladder cancer except:
A- U/S
B- IVU
C- CT
D- Plain KUB

9. Bladder cancer, MCQ
• Q7- The gold standard imaging modality for
diagnosis of bladder cancer is:
A- IVU
B- CT with contrast
C- MRI
D- U/S

11. Bladder cancer, MCQ
Q8- C.T. with contrast gives excellent data
about:
A- Morphology of upper and lower UT
B-Relations of UT to adjacent organs
C- Pelvic and abdominal L.N.
D- All of the above

12. Bladder cancer, MCQ
Q9- Superficial, non muscle invasive, bladder
cancer constitutes:
A- 60-75% of B ca
B- 40-50% of B ca
C- 80-90% of B ca
D- 30-40% of B ca

13. Bladder cancer, MCQ
Q10- Which percentage of non muscle invasive
B ca progress to invasive disease:
A- 10-20%
B- 30-40%
C- 40-50%
D- 50-60%

14. Q 11
Type of x-ray
Pathology
Site

15. Q 12
Pathology in Rt and Lt
Main Presentation

17. Bladder cancer, MCQ
Q13
According to TNM staging system,
Mention 3 different pathological types of TCC

18. Bladder cancer, MCQ
Q14
How to stage Bladder cancer
A- Bimanual examination under anaesth.
B- Cystoscopy and biopsy
C- C.T. abdomen and pelvis
D- Chest x-ray, Bone scan.
E- All of the above

19. Bladder cancer, MCQ
Q15
Lines of treatment of superficial bladder cancer:
A- Transurethral resection (TURT)
B- Intravesical BCG
C- Intravesical Chemo
D- All of the above

20. Bladder cancer, MCQ
Q16
Follow up by Cystoscopy&urine cytology for
superficial bladder cancer may extend for:
A- one year
B- two years
C- Three Years
D- Longer periods

21. Bladder cancer, MCQ
Q17
Standard treatment of first occurrence of CIS is:
A- TURT and I.V. BCG
B- TURT alone
C- TURT and I.V. chemo
D- Radical cystectomy

22. Bladder cancer, MCQ
Q18
Standard treatment for muscle invasive B Ca:
A- Radical cystectomy
B- Chemtherapy
C- Radiotherapy
D- Chemtherapy and Radiotherapy

23. Bladder cancer, MCQ
Q19
Treatment of muscle invasive B Ca by TURT,
Chemo and XRT is indicated in highly
selected cases or refusal of cystectomy
A- True
B- False

24. Bladder cancer, MCQ
Q20
The standard treatment for metastatic B Ca is:
A- Radiotherapy
B- Chemotherapy
C- Cystectomy
D- Immunotherapy

25. Thank you